RedHill Biopharma Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · Israel

Last price 0.4166 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.53M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; ...